Understanding the pathogenic mechanisms of Aβ and tau in the AD brain is particularly important for AD prevention and treatment (Buckley and Kelly, 1985; Ma et al., 2018; Mcinnes et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.